Show More From the Division of Gynecologic Oncology, New York University School of Medicine, New York, NY. Leiomyosarcoma, the most frequent pure uterine sarcoma, is an aggressive tumor with a ...

Comparison of Referring and Final Pathology for Patients With Non-Hodgkin's Lymphoma in the National Comprehensive Cancer Network To evaluate morbidity, mortality, and overall and disease-free ...

CHICAGO -- High-dose ifosfamide proved more effective at prolonging event-free survival (EFS) and overall survival (OS) than topotecan plus cyclophosphamide in relapsed/refractory Ewing sarcoma, ...

Champions Oncology (NASDAQ: CSBR) today announced that it has initiated a sponsored prospective correlative trial of patient derived xenograft modeling (PDX or Champions TumorGraft ® PDX models) in ...

Ewing sarcoma is a malignant type of bone tumor, meaning it is a form of cancer that spreads. According to a 2024 review, Ewing sarcoma is the second most common primary cancerous bone tumor. It ...

The optimal negative margin required following surgical resection and perioperative radiotherapy for extremity soft tissue sarcoma (STS) remains up for debate, with investigators of a new study using ...

A research team at University of California, Los Angeles (UCLA), funded by Cancervax Inc., has created a promising new bispecific antibody vaccine for treating recurrent Ewing sarcoma. This treatment ...

Please provide your email address to receive an email when new articles are posted on . Five-year local recurrence rates were 10% and 17% for atypical fibroxanthoma and pleomorphic dermal sarcoma, ...